Log In
Print this Print this

Semprana, dihydroergotamine (formerly Levadex, MAP0004)

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionDihydroergotamine (DHE) mesylate compound that agonizes the serotonin (5-HT) receptor and is delivered via Map's Tempo Inhaler
Molecular Target Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT1D) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationMigraine
Indication DetailsTreat acute migraine; Treat acute migraine in patients with compromised lung function
Regulatory Designation

U.S. - Undisclosed Review (Treat acute migraine)


Nektar Therapeutics

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today